GTCM
VERA icon

Gyon Technologies Capital Management’s Vera Therapeutics VERA Stock Holding History

Gyon Technologies Capital Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9,413
Closed -$182K – 404
2022
Q4 		$182K Sell
9,413
-11,018
-54% -$200K 0.07% 307
2022
Q3 		$435K Buy
+20,431
New +$382K 0.14% 161
2022
Q2 		– Sell
-16,961
Closed -$398K – 568
2022
Q1 		$398K Sell
16,961
-7,592
-31% -$163K 0.28% 129
2021
Q4 		$656K Buy
24,553
+5,511
+29% +$122K 0.12% 234
2021
Q3 		$330K Buy
+19,042
New +$340K 0.09% 273

Other funds holding VERA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gyon Technologies Capital Management's VERA Position: Q1 2023 in Review

Gyon Technologies Capital Management sold out of Vera Therapeutics (VERA) in Q1 2023, closing a stake of 9,413 shares — an estimated $182K sold.

Gyon Technologies Capital Management first reported a position in VERA in Q3 2021 and held it in 5 quarters. The position peaked at $656K in Q4 2021. 70 funds tracked by Wall St. Rank hold VERA as of Q1 2023.

  • Gyon Technologies Capital Management reported no remaining Vera Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 9,413 Vera Therapeutics shares in Q1 2023, an estimated $182K.
  • Gyon Technologies Capital Management first reported a position in Vera Therapeutics in Q3 2021 and held it in 5 quarters.
  • Gyon Technologies Capital Management's Vera Therapeutics position peaked at $656K in Q4 2021.
  • 70 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2023.

Based on Gyon Technologies Capital Management's 13F filing for Q1 2023.